Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Kawashima
OpenAlex ID:
A5036762849
S195: Momentum: Phase 3 Randomized Study of Momelotinib (mmb) Versus Danazol (dan) in Symptomatic and Anemic Myelofibrosis (mf) Patients Previously Treated With a Jak Inhibitor
2022
·
S. Verstovsek
, A. Vannucchi
, et al.
·
HemaSphere
·
5
P1050: Thrombocytopenic Myelofibrosis (mf) Patients Previously Treated With a Jak Inhibitor in a Phase 3 Randomized Study of Momelotinib (mmb) Versus Danazol (dan) [momentum]
2022
·
A. Vannucchi
, R. Mesa
, et al.
·
HemaSphere
·
1
Show more works
View as search
Works count:
2
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type
